Publications by authors named "X Lafarge"

Claim this Profile
R
Reassessing the cryopreserved human amniotic membrane's low immunogenicity due to advances in histocompatibility.
Jean-Baptiste Baudey, Lauriana Solecki, Christophe Picard, Pascal Pedini, Bastien Mathéaud, Xavier Lafarge

Mater Today Bio· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[End of COBE2991®: What alternatives are available for the preparation of each type of cell therapy products? (SFGM-TC)].
Justine Nasone, Carina Alves Goncalves, Caroline Ballot, Ulrick Birba, Maxime Bouabdelli, Xavier Lafarge

Bull Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bifunctional chimeras of myeloperoxidase and glucose oxidase. Antimicrobial, topological and enzymatic properties.
Parfait Kenfack Ymbe, Claire Céré, Brigitte Delord, Gilles Pecastaings, Isabelle Ly, Xavier Lafarge

J Biotechnol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo assessment of a new acellular human amnion/chorion membrane device for guided bone regeneration.
Paul Galvez, Naïma Ahmed Omar, Robin Siadous, Marlène Durand, Léo Comperat, Xavier Lafarge

Sci Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convalescent plasma transfusion for immunocompromised viremic patients with COVID-19: A retrospective multicenter study.
Marjolaine Destremau, Hélène Chaussade, Victor Hemar, Mathilde Beguet, Pantxika Bellecave, Xavier Lafarge

J Med Virol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis